Kanabo has set up an R&D lab in the Weizmann Science Park. The company has obtained the necessary Cannabis R&D licenses, and has partnered with analytical labs to conduct third-party independent testing for all products. To date, Kanabo has developed a proprietary, patent-pending formula for sleep disorders (insomnia); three proprietary CBD formulations for Focus, Serenity, and Revive and the VapePod vaporization delivery device. Kanabo has already conducted pre-clinical trials on the sleep disorders formula. Additional pre-clinical and medical validation activities are underway and in continued development at the R&D lab and through a CRO partner. This includes preparation for clinical trials at one of the leading hospitals in Israel. U.S. patent-pending for the sleep disorders formula through a pharmaceutical patent firm.